Related Experiment Video

Updated: Jan 11, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.6K

Short-Term Outcomes of Micropulse Transscleral Cyclophotocoagulation Using the VITRA 810 and Postoperative

So Handa1, Takahiro Kawaji2, Shin-Ichi Otsuka1

  • 1Otsuka Eye Clinic, 3-12-69 Tanaka-machi, Oita 870-0852, Japan.

Journal of Clinical Medicine
|November 13, 2025
PubMed

Insights

Micropulse transscleral cyclophotocoagulation (MP-TSCPC) with VITRA 810 significantly lowered intraocular pressure (IOP) in Japanese patients short-term. Ciliochoroidal effusion correlated with greater early IOP reduction, but rare severe complications warrant monitoring.

Area of Science:

  • Ophthalmology
  • Glaucoma Treatment
  • Medical Devices

Background:

  • Micropulse transscleral cyclophotocoagulation (MP-TSCPC) is a glaucoma treatment.
  • The VITRA 810 is a specific device used for MP-TSCPC.
  • Japanese patients represent a specific demographic for this study.

Purpose of the Study:

  • To evaluate the short-term efficacy and safety of VITRA 810 MP-TSCPC.
  • To assess intraocular pressure (IOP) reduction.
  • To analyze complications and ciliochoroidal effusion (CE).

Main Methods:

  • Retrospective review of 37 eyes from 34 patients.
  • Analysis of postoperative IOP, glaucoma medication scores, complications, and CE via anterior segment OCT.
  • Comparison of IOP changes between CE-positive and CE-negative groups.

Main Results:

  • Significant IOP reduction observed from baseline at all follow-up points (1 week to 6 months).
  • Ciliochoroidal effusion (CE) occurred in 59.4% of eyes and was linked to greater early IOP reduction.
  • Common complications included mydriasis and anterior chamber inflammation; rare severe complications like phthisis bulbi were noted.

Conclusions:

  • VITRA 810 MP-TSCPC provides effective short-term IOP lowering in Japanese patients.
  • CE is associated with enhanced early IOP reduction following MP-TSCPC.
  • While generally safe, vigilance for rare severe complications is crucial.
Keywords:
JapanMP-TSCPCVITRA 810ciliochoroidal effusionglaucomamicropulse transscleral cyclophotocoagulationphthisis bulbi

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.8K
Iris Fixation via External Pentagram Suturing05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.7K

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
940